PTJ
RPTX

Paul Tudor Jones’s Repare Therapeutics RPTX Stock Holding History

Paul Tudor Jones’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,034
Closed -$251K – 2877
2022
Q4 		$251K Buy
+17,034
New +$255K 0.01% 2019
2022
Q2 		– Sell
-20,817
Closed -$296K – 2466
2022
Q1 		$296K Buy
+20,817
New +$309K 0.01% 1563
2021
Q1 		– Sell
-11,502
Closed -$395K – 1814
2020
Q4 		$395K Sell
11,502
-12,105
-51% -$362K 0.01% 1030
2020
Q3 		$726K Sell
23,607
-10,306
-30% -$273K 0.03% 679
2020
Q2 		$1.05M Buy
+33,913
New +$1.09M 0.05% 452

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Paul Tudor Jones's RPTX Position: Q1 2023 in Review

Paul Tudor Jones sold out of Repare Therapeutics (RPTX) in Q1 2023, closing a stake of 17,034 shares — an estimated $251K sold.

Paul Tudor Jones first reported a position in RPTX in Q2 2020 and held it in 5 quarters. The position peaked at $1.05M in Q2 2020. 77 funds tracked by Wall St. Rank hold RPTX as of Q1 2023.

  • Paul Tudor Jones reported no remaining Repare Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 17,034 Repare Therapeutics shares in Q1 2023, an estimated $251K.
  • Paul Tudor Jones first reported a position in Repare Therapeutics in Q2 2020 and held it in 5 quarters.
  • Paul Tudor Jones's Repare Therapeutics position peaked at $1.05M in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.